Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC)

53 filings reported holding OACC - Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share as of Q3 2025.
Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 16.4M shares of 19.6M outstanding shares and own 83.59% of the company stock.
Largest 10 shareholders include AQR Arbitrage LLC (1.41M shares), TORONTO DOMINION BANK (934K shares), D. E. Shaw & Co., Inc. (862K shares), Boussard & Gavaudan Investment Management LLP (750K shares), Empyrean Capital Partners, LP (750K shares), Driehaus Capital Management LLC (713K shares), HighTower Advisors, LLC (658K shares), Decagon Asset Management LLP (644K shares), Linden Advisors LP (600K shares), and GOLDMAN SACHS GROUP INC (530K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.